Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures (CARDIF)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2015 by Charite University, Berlin, Germany
Sponsor:
Collaborator:
Charité Neurocure AG Flöel
Information provided by:
Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT01370044
First received: May 20, 2011
Last updated: May 5, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: September 2017 (Final data collection date for primary outcome measure)